This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The New York Times
nytimes.com
did:plc:eclio37ymobqex2ncko63h4r
A drug nearing regulatory approval, daraxonrasib, is the first to substantially extend the lives of patients with pancreatic cancer, one of the most dire diagnoses in medicine. Here’s how scientists discovered it. nyti.ms/42uJq14
2026-05-12T15:35:50.479Z